Back to ELVN
Commodore Capital LP ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$150.1M
Q3 2026
Peak value
$166.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $72.3M |
| Q1 2026 | $128.4M |
| Q2 2026 | $166.2M |
| Q3 2026 | $150.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $150.1M | 3.27M | — | — |
| Q2 2026 | $166.2M | 3.27M | — | — |
| Q1 2026 | $128.4M | 3.27M | — | — |
| Q4 2025 | $72.3M | 4.69M | — | — |
Other funds holding ELVN
$449.6M
$394.2M
$343.9M
$326.4M
$312M
$310.6M
$294.5M
$261.1M